## AME: AMETEK, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.5% below STRENGTH zone (3.0-6.0%); PEG 2.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($194.36)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. FORA Capital LLC Purchases 7,648 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251214T092027 | Somewhat-Bullish | Relevance: 100%
- FORA Capital LLC has significantly increased its stake in AMETEK, Inc. by 143.9%, acquiring an additional 7,648 shares, bringing its total to 12,962 shares valued at approximately $2.346 million. This increase comes as AMETEK outperforms Q3 earnings estimates and provides strong FY2025 guidance. Despite insider sales totaling around $28.27 million in the last quarter, analysts maintain a "Moderate Buy" consensus for AMETEK with a target price of $213.08.

**2. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in AMETEK, Inc. $AME**
- Source: MarketBeat | 20251212T110742 | Bullish | Relevance: 100%
- OCONNOR, a unit of UBS Asset Management, recently established a new stake in AMETEK, Inc. (NYSE:AME) by acquiring 6,085 shares valued at approximately $1.10 million. This move coincides with an increase in institutional ownership, now at around 87.4%, and positive analyst revisions, leading to a "Moderate Buy" consensus rating and an average target price of $213.08. The article also highlights AMETEK's strong quarterly performance, dividend declaration, and recent insider stock sales by the CEO and another insider.

**3. Lazard Asset Management LLC Buys 287,304 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251214T134146 | Somewhat-Bullish | Relevance: 100%
- Lazard Asset Management LLC increased its stake in AMETEK, Inc. (NYSE:AME) by 17.3% in the second quarter, acquiring an additional 287,304 shares. The firm now holds 1,950,558 shares valued at approximately $352.97 million, representing about 0.84% of the company. AMETEK reported strong Q3 earnings, beating consensus estimates, and provided positive guidance for Q4 and the full fiscal year 2025.

**4. HRT Financial LP Acquires 70,419 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251214T131946 | Somewhat-Bullish | Relevance: 100%
- HRT Financial LP significantly increased its stake in AMETEK, Inc. by 179.1% in Q2, acquiring an additional 70,419 shares to hold a total of 109,733 shares valued at approximately $19.86 million. This move comes amidst recent insider selling by executives Ronald J. Oscher and David A. Zapico, who collectively offloaded 142,680 shares. AMETEK, Inc. has shown strong financial performance, beating quarterly estimates and receiving a "Moderate Buy" consensus rating from analysts with an average target price of $213.08.

**5. KP Management LLC Sells 12,219 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251214T111521 | Neutral | Relevance: 100%
- KP Management LLC significantly reduced its stake in AMETEK, Inc. by 59.6%, selling 12,219 shares and valuing its remaining holdings at $1.50 million. Despite institutional investors owning 87.43% of the company, insiders have been net sellers, with the CEO and another executive selling shares worth millions. AMETEK, however, has exceeded quarterly earnings and revenue estimates and maintains a "Moderate Buy" consensus rating among analysts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | DA Davidson | $240 | $235 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.91M) |
| Sells | 2 ($0.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+0.6%)
- Blackrock Inc.: 8.5% (-0.9%)
- Price (T.Rowe) Assoc: 4.3% (-7.3%)
- State Street Corpora: 4.2% (+1.3%)
- JPMORGAN CHASE & CO: 3.6% (+77.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +2.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.75 signals overvaluation risk, limited margin of safety. Forward P/E 25.3x stretched relative to 8% growth. Quality metrics strong (margin 20%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.6B |
| Beta | 1.05 |
| 52W Range | $145.02 - $204.43 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.75 |
| Forward P/E | 25.3 |
| Current P/E | 27.5 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.1% to 2.5% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.5pp (needs >3.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.53% (CS: 59) | Neutral |
| RSI_14 | 59.8 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.049x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $201.74
- **Stop Loss:** $194.36 (3.7% risk)
- **Target:** $209.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 162
- **Position Value:** $32,681.88
- **Portfolio %:** 32.68%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-03 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.76 | $1.89 | +7.4% |
| 2025Q2 | $1.69 | $1.78 | +5.5% |
| 2025Q1 | $1.69 | $1.75 | +3.5% |
| 2024Q4 | $1.85 | $1.87 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*